Evidence map›Paper›PMID 42199380›Full record

ArticleACG case reports journal2026

Hepatic Amyloid Light-Chain Amyloidosis Incidentally Diagnosed via Endoscopic Ultrasound-Guided Liver Biopsy.

Yuta Tsujiguchi, Tsuyoshi Suda, Tatsuya Imi, Miyabi Miura, Kiichiro Kaji, Kuniaki Arai, Kenichi Harada, Shuichi Terasaki

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuta TsujiguchiDepartment of Gastroenterology, Kanazawa Red Cross Hospital, Kanazawa, Ishikawa, Japan.
Tsuyoshi SudaDepartment of Gastroenterology, Kanazawa Red Cross Hospital, Kanazawa, Ishikawa, Japan.ORCID https://orcid.org/0000-0001-9608-0444
Tatsuya ImiDepartment of Hematology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
Miyabi MiuraDepartment of Gastroenterology, Kanazawa Red Cross Hospital, Kanazawa, Ishikawa, Japan.
Kiichiro KajiDepartment of Gastroenterology, Kanazawa Red Cross Hospital, Kanazawa, Ishikawa, Japan.
Kuniaki AraiDepartment of Gastroenterology, Kanazawa Red Cross Hospital, Kanazawa, Ishikawa, Japan.
Kenichi HaradaDepartment of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan.
Shuichi TerasakiDepartment of Gastroenterology, Kanazawa Red Cross Hospital, Kanazawa, Ishikawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic amyloid light-chain (AL) amyloidosis is characterized by amyloid protein deposition in the liver, requiring biopsy for diagnosis. We report a 71-year-old man with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia presenting with hepatomegaly and elevated enzymes. Imaging revealed no masses. The patient was diagnosed with hepatic AL amyloidosis through repeat endoscopic ultrasound-guided liver biopsy (EUS-LB), following an initial inconclusive result. A postprocedural hepatic hematoma resolved within 2 months. To the best of our knowledge, cases of hepatic AL amyloidosis diagnosed through EUS-LB are scarce. This case illustrates the diagnostic utility of EUS-LB in hepatic AL amyloidosis and highlights the need for careful interpretation of postprocedural findings.

Indexed as

bleeding riskendoscopic ultrasound-guided liver biopsyhepatic AL amyloidosishepatic hematoma

Identifiers

PMID42199380
PMCPMC13200912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.